Home › Funds › CPP Investments › AMRX
CPP Investments position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Latest position (Q1 2026)35.40K sh
Reported value held$440.02K
Portfolio Weight0.00%
First reportedQ2 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 3.00K | $19.05K | New |
| Q3 2024 | 357.00K | $2.97M | Add |
| Q4 2024 | 365.30K | $2.89M | Add |
| Q1 2025 | 43.20K | $362.02K | Reduce |
| Q2 2025 | 21.40K | $173.13K | Reduce |
| Q3 2025 | 21.00K | $210.21K | Reduce |
| Q4 2025 | 46.60K | $587.16K | Add |
| Q1 2026 | 35.40K | $440.02K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMRX
- BlackRock Inc 26.56M sh · $459.79M · Q2 2026
- Vanguard Group 17.91M sh · $225.64M · Q4 2025
- Geode Capital Management 5.14M sh · $88.98M · Q2 2026
- Morgan Stanley 4.11M sh · $71.14M · Q2 2026
- Invesco Ltd 3.50M sh · $60.62M · Q2 2026
- Goldman Sachs Group 3.01M sh · $52.17M · Q2 2026
- Charles Schwab Investment Management 2.15M sh · $37.17M · Q2 2026
- Northern Trust Corp 1.91M sh · $33.15M · Q2 2026
- Citadel Advisors 1.15M sh · $19.87M · Q2 2026
- BNY Mellon 1.02M sh · $17.57M · Q2 2026
- Principal Global Investors 991.82K sh · $17.17M · Q2 2026
- Fidelity Management & Research (FMR) 825.12K sh · $14.28M · Q2 2026